Toxicity

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Toxicity

posted on Nov 02, 2022 03:10PM

It looks like one of the NCI trials has been discontinued due to unacceptable toxicity.

The trial was in Phase 1 for advanced or unresectable solid tumors with RAS alternations or TNBC, in comination with Binimetinib.

https://clinicaltrials.gov/ct2/show/NCT05111561

Another trial was suspended, "to address important protocol updates". Not sure what that means.

https://clinicaltrials.gov/ct2/show/NCT05372640?term=zen-3694&draw=3&rank=12

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply